In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits brought by users of Zantac, it appeared that the drugmaker’s legal issues with the heartburn ...

GSK plc (NYSE:GSK) – GSK agreed to pay up to $2.2 billion to settle 93% of U.S. lawsuits related to Zantac, alleging the drug caused cancer. The settlement, announced Wednesday, was lower than ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

Global pharmaceutical company GSK Plc allegedly deceived investors when it concealed for decades an internal study implicating a link between the heartburn drug Zantac and cancer, a proposed class ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between ...

In 2019, independent laboratory Valisure found NDMA, a cancer-causing poison, in “every batch of every [Zantac] medication” that it tested. Valisure reported these results to the U.S. Food and ...

In 2019, independent laboratory Valisure found NDMA, a cancer-causing poison, in “every batch of every [Zantac] medication” that it tested. Valisure reported these results to the U.S. Food and ...

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit in the U.S. District Court for the Eastern District of Pennsylvania alleging ...

Eye drops for pink eye include both over-the-counter (OTC) and prescription medication. Prescriptions may be antiviral or antibiotic eye drops, depending on the underlying cause. The body can fight ...